Laura Decastro is a Hematology physician affiliated with University of Pittsburgh. OpenAlex indexes 45 publications with 2,448 citations (h-index 16); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5150 Centre Ave
5th Fl. Room 562
Pittsburgh, PA 152321309
Telephone
412-623-7026Registry record last updated 5 Feb 2014.
Clinical trials
- Effectiveness of Arginine as a Treatment for Sickle Cell Anemia
Sponsor: UCSF Benioff Children's Hospital Oakland
- Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Sponsor: University of Texas Southwestern Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20245 payments
- Novartis Pharmaceuticals CorporationProgram year20222 payments
- NOVARTIS PHARMACEUTICALS CORPORATIONProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
50%Opioid Agonist50%Oxycodone Hcl48%Morphine Sulfate Er20%Oxymorphone Hcl Er12%Methadone Hcl10%Hydromorphone Hcl10%Part D<11 patientsBlood & clotting
27%Factor Xa inhibitor18.1%Eliquis71%Xarelto29%Part D<11 patientsHemoglobin S Polymerization Inhibitor8.8%Oxbryta100%Part D<11 patientsCancer & immunology
18.1%Antimetabolite18.1%Hydroxyurea100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Toren Finkel, MD/PHD
University of Pittsburgh
Sally Wenzel, MD
University of Pittsburgh
Mary Phillips, MD
University of Pittsburgh
Jared Magnani, MD, MSc
University of Pittsburgh
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”